[3H]OT (human, mouse, rat) [8014]
[3H]OT (human, mouse, rat)
| SMILES |
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O |
| InChIKey |
XNOPRXBHLZRZKH-DSZYJQQASA-N |
| Sequence |
CYIQNCPLG |
| HELM |
PEPTIDE1{C.Y.I.Q.N.C.P.L.G.[am]}$PEPTIDE1,PEPTIDE1,6:R3-1:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors |
15 |
| Hydrogen bond donors |
12 |
| Rotatable bonds |
17 |
| Log P |
-3.609 |
| Molecular weight (Da) |
1006.4 |
| Stereochemistry info |
partial |
| Radioactive |
3H |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[3H]OT (human, mouse, rat)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.